ΔNp73 Enhances Promoter Activity of TGF-β Induced Genes

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Niemantsverdriet, Maarten ^a   Nagle, Peter ^a   Chiu, Roland K ^a   Langendijk, Johannes A ^a   Kampinga, Harm H ^a   Coppes, Robert P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P73; SMAD BINDING ELEMENT; SMAD PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TETRACYCLINE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CHROMATIN IMMUNOPRECIPITATION; COL1A1 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PAI 1 GENE; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PULL DOWN ASSAY; SIGNAL TRANSDUCTION; TRANSACTIVATION;

CELL LINE; DNA-BINDING PROTEINS; HUMANS; NUCLEAR PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84870939539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050815     Document Type: Article

References (53)

1. Melino G, De Laurenzi V, Vousden KH, (2002) p73: Friend or foe in tumorigenesis. Nat Rev Cancer 2: 605-615.
2. Muller M, Schleithoff ES, Stremmel W, Melino G, Krammer PH, et al. (2006) One, two, three-p53, p63, p73 and chemosensitivity. Drug Resist Updat 9: 288-306.
3. Oswald C, Stiewe T, (2008) In good times and bad: p73 in cancer. Cell Cycle 7: 1726-1731.
4. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.
5. Ko LJ, Prives C, (1996) p53: puzzle and paradigm. Genes Dev 10: 1054-1072.
6. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, et al. (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404: 99-103.
7. Vilgelm AE, Hong SM, Washington MK, Wei J, Chen H, et al. (2010) Characterization of DeltaNp73 expression and regulation in gastric and esophageal tumors. Oncogene 29: 5861-5868.
8. Fujitani M, Cancino GI, Dugani CB, Weaver IC, Gauthier-Fisher A, et al. (2010) TAp73 acts via the bHLH Hey2 to promote long-term maintenance of neural precursors. Curr Biol 20: 2058-2065.
9. Killick R, Niklison-Chirou M, Tomasini R, Bano D, Rufini A, et al. (2011) p73: a multifunctional protein in neurobiology. Mol Neurobiol 43: 139-146.
10. Tomasini R, Tsuchihara K, Wilhelm M, Fujitani M, Rufini A, et al. (2008) TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 22: 2677-2691.
11. Wilhelm MT, Rufini A, Wetzel MK, Tsuchihara K, Inoue S, et al. (2010) Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway. Genes Dev 24: 549-560.
12. Cordenonsi M, Dupont S, Maretto S, Insinga A, Imbriano C, et al. (2003) Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads. Cell 113: 301-314.
13. Takebayashi-Suzuki K, Funami J, Tokumori D, Saito A, Watabe T, et al. (2003) Interplay between the tumor suppressor p53 and TGF beta signaling shapes embryonic body axes in Xenopus. Development 130: 3929-3939.
14. Piccolo S, (2008) p53 regulation orchestrates the TGF-beta response. Cell 133: 767-769.
15. Whitman M, McKeon F, (2003) p53 and TGF-beta in development: prelude to tumor suppression? Cell 113: 275-276.
16. Wu MY, Hill CS, (2009) Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell 16: 329-343.
17. Elliott RL, Blobe GC, (2005) Role of transforming growth factor Beta in human cancer. J Clin Oncol 23: 2078-2093.
18. Massague J, (2000) How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1: 169-178.
19. Schmierer B, Hill CS, (2007) TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8: 970-982.
20. Siegel PM, Massague J, (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer 3: 807-821.
21. Wakefield LM, Roberts AB, (2002) TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29.
22. Derynck R, Akhurst RJ, Balmain A, (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129.
23. Andreasen PA, (2007) PAI-1- a potential therapeutic target in cancer. Curr Drug Targets 8: 1030-1041.
24. Dellas C, Loskutoff DJ, (2005) Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 93: 631-640.
25. Rundle CH, Wang X, Wergedal JE, Mohan S, Lau KH, (2008) Fracture healing in mice deficient in plasminogen activator inhibitor-1. Calcif Tissue Int 83: 276-284.
26. Hageman J, Eggen BJ, Rozema T, Damman K, Kampinga HH, et al. (2005) Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene. Clin Cancer Res 11: 5956-5964.
27. Niemantsverdriet M, de Jong E, Langendijk JA, Kampinga HH, Coppes RP, (2010) Synergistic induction of profibrotic PAI-1 by TGF-beta and radiation depends on p53. Radiother Oncol 97: 33-35.
28. Niemantsverdriet M, Jongmans W, Backendorf C, (2005) Radiation response and cell cycle regulation of p53 rescued malignant keratinocytes. Exp Cell Res 310: 237-247.
29. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, et al. (1997) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389: 631-635.
30. De Laurenzi V, Costanzo A, Barcaroli D, Terrinoni A, Falco M, et al. (1998) Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med 188: 1763-1768.
31. Grob TJ, Novak U, Maisse C, Barcaroli D, Luthi AU, et al. (2001) Human delta Np73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ 8: 1213-1223.
32. Lasfer M, Davenne L, Vadrot N, Alexia C, Sadji-Ouatas Z, et al. (2006) Protein kinase PKC delta and c-Abl are required for mitochondrial apoptosis induction by genotoxic stress in the absence of p53, p73 and Fas receptor. FEBS Lett 580: 2547-2552.
33. Wierenga AT, Eggen BJ, Kruijer W, Vellenga E, (2002) Proteolytic degradation of Smad4 in extracts of AML blasts. Leuk Res 26: 1105-1111.
34. Markl B, Renk I, Oruzio DV, Jahnig H, Schenkirsch G, et al. (2010) Tumour budding, uPA and PAI-1 are associated with aggressive behaviour in colon cancer. J Surg Oncol 102: 235-241.
35. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, et al. (1998) Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. Embo J 17: 3091-3100.
36. Saramaki A, Banwell CM, Campbell MJ, Carlberg C, (2006) Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res 34: 543-554.
37. Nakagawa T, Takahashi M, Ozaki T, Watanabe Ki K, Todo S, et al. (2002) Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. Mol Cell Biol 22: 2575-2585.
38. Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, et al. (2002) DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors. J Exp Med 196: 765-780.
39. Jonk LJ, Itoh S, Heldin CH, ten Dijke P, Kruijer W, (1998) Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273: 21145-21152.
40. Dotsch V, Bernassola F, Coutandin D, Candi E, Melino G, (2010) p63 and p73, the ancestors of p53. Cold Spring Harb Perspect Biol 2: a004887.
41. Boldrup L, Coates PJ, Gu X, Nylander K, (2007) DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck. J Pathol 213: 384-391.
42. Craig AL, Holcakova J, Finlan LE, Nekulova M, Hrstka R, et al. (2010) DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation. Mol Cancer 9: 195.
43. Liu G, Nozell S, Xiao H, Chen X, (2004) DeltaNp73beta is active in transactivation and growth suppression. Mol Cell Biol 24: 487-501.
44. de Caestecker MP, Hemmati P, Larisch-Bloch S, Ajmera R, Roberts AB, et al. (1997) Characterization of functional domains within Smad4/DPC4. J Biol Chem 272: 13690-13696.
45. de Winter JP, Roelen BA, ten Dijke P, van der Burg B, van den Eijnden-van Raaij AJ, (1997) DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 14: 1891-1899.
46. Keeton MR, Curriden SA, van Zonneveld AJ, Loskutoff DJ, (1991) Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J Biol Chem 266: 23048-23052.
47. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, et al. (2004) Gene expression profile of gastric carcinoma: identification of genes and tags potentially involved in invasion, metastasis, and carcinogenesis by serial analysis of gene expression. Cancer Res 64: 2397-2405.
48. Samuel MS, Lopez JI, McGhee EJ, Croft DR, Strachan D, et al. (2011) Actomyosin-Mediated Cellular Tension Drives Increased Tissue Stiffness and beta-Catenin Activation to Induce Epidermal Hyperplasia and Tumor Growth. Cancer Cell 19: 776-791.
49. Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H, (2004) Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 95: 385-392.
50. Falanga V, Zhou L, Yufit T, (2002) Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-beta1. J Cell Physiol 191: 42-50.
51. Vella V, Puppin C, Damante G, Vigneri R, Sanfilippo M, et al. (2009) DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells. Int J Cancer 124: 2539-2548.
52. Liu SS, Chan KY, Cheung AN, Liao XY, Leung TW, et al. (2006) Expression of deltaNp73 and TAp73alpha independently associated with radiosensitivities and prognoses in cervical squamous cell carcinoma. Clin Cancer Res 12: 3922-3927.
53. Uramoto H, Sugio K, Oyama T, Nakata S, Ono K, et al. (2004) Expression of deltaNp73 predicts poor prognosis in lung cancer. Clin Cancer Res 10: 6905-6911.